XML 60 R26.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Stock-Based Compensation Expense Recorded in Statements of Operations The Company recorded stock-based compensation expense in the following expense categories in its accompanying statements of operations:

 

 

 

Year Ended

December 31,

 

(in thousands)

 

2021

 

 

2020

 

Research and development

 

$

9,469

 

 

$

2,585

 

General and administrative

 

 

11,462

 

 

 

2,998

 

 

 

$

20,931

 

 

$

5,583

 

 

Summary of Stock Option Activity

The following table summarizes stock option activity for the Plan in the years indicated:

 

 

 

Number

of shares

 

 

Weighted

average

exercise price

per share

 

 

Weighted

average

remaining

contractual

term (years)

 

Outstanding at January 1, 2020

 

 

2,269,742

 

 

$

1.66

 

 

 

9.20

 

Granted

 

 

4,785,630

 

 

$

11.35

 

 

 

 

 

Exercised

 

 

(100,545

)

 

$

0.99

 

 

 

 

 

Forfeited

 

 

(115,736

)

 

$

1.37

 

 

 

 

 

Outstanding at December 31, 2020

 

 

6,839,091

 

 

$

8.46

 

 

 

9.17

 

Granted

 

 

2,600,231

 

 

$

31.14

 

 

 

 

 

Exercised

 

 

(995,950

)

 

$

3.52

 

 

 

 

 

Forfeited

 

 

(1,263,890

)

 

$

19.79

 

 

 

 

 

Outstanding at December 31, 2021

 

 

7,179,482

 

 

$

15.36

 

 

 

8.66

 

Exercisable at December 31, 2021

 

 

2,057,975

 

 

$

6.99

 

 

 

8.04

 

Summary of Information about Stock Options Outstanding

The following table summarizes information about stock options outstanding and exercisable at December 31, 2021 under the Plan:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Range of Exercise Prices

 

Number

Outstanding

 

 

Weighted

Average

Remaining

Contractual Life

(in years)

 

 

Weighted

Average

Exercise

Price

 

 

Number

Exercisable

 

 

Weighted

Average

Exercise

Price

 

$0.31 - $7.37

 

 

2,352,647

 

 

 

7.76

 

 

$

1.80

 

 

 

1,233,638

 

 

$

1.75

 

$7.38 - $13.08

 

 

2,465,488

 

 

 

8.67

 

 

 

12.85

 

 

 

777,587

 

 

 

12.85

 

$13.09 - $31.30

 

 

1,760,632

 

 

 

9.61

 

 

 

27.58

 

 

 

4,219

 

 

 

17.99

 

$31.31 - $88.98

 

 

600,715

 

 

 

9.35

 

 

 

43.02

 

 

 

42,531

 

 

 

50.79

 

 

 

 

7,179,482

 

 

 

 

 

 

 

 

 

 

 

2,057,975

 

 

 

 

 

Schedule of Fair Value of Each Option Estimated on Date of Grant Using Weighted Average Assumptions

The fair value of each option was estimated on the date of grant using the weighted average assumptions in the table below:

 

 

 

Year Ended

December 31,

 

 

 

2021

 

 

2020

 

Expected volatility

 

 

87.46

%

 

 

115.17

%

Risk-free interest rate

 

 

0.94

%

 

 

0.43

%

Expected life (in years)

 

 

6.04

 

 

 

6.25

 

Expected dividend yield

 

 

 

 

 

 

Summary of Activity related to RSA Stock-Based Payment Awards

The following table summarizes activity related to RSA stock-based payment awards:

 

 

 

Number of

shares

 

 

Weighted-

average

grant date

fair value

 

Unvested balance at January 1, 2020

 

 

1,335,349

 

 

$

1.42

 

Granted

 

 

432,301

 

 

$

3.26

 

Vested

 

 

(552,883

)

 

$

1.37

 

Unvested balance at December 31, 2020

 

 

1,214,767

 

 

$

2.09

 

Vested

 

 

(603,159

)

 

$

1.89

 

Unvested balance at December 31, 2021

 

 

611,608

 

 

$

2.29

 

Summary of Activity related to RSU Stock-Based Payment Awards

The following table summarizes activity related to RSU stock-based payment awards:

 

 

Number of

shares

 

 

Weighted-

average

grant date

fair value

 

Outstanding at January 1, 2021

 

 

 

 

 

 

 

Granted

 

 

45,000

 

 

$

26.91

 

Forfeited

 

 

(25,000

)

 

$

33.78

 

Outstanding at December 31, 2021

 

 

20,000

 

 

$

18.32